BackNovo Nordisk Overview

Novo Nordisk Other Current Liabilities

Track Novo Nordisk's other current liabilities ($45B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$45.50B
↓ 69.75% YoYΔ $-104.93B vs prior year quarter

Peer trimmed avg / median

Loading

Novo Nordisk Other Current Liabilities History

Loading

Novo Nordisk vs. peers: Other Current Liabilities Comparison

Loading

Novo Nordisk Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novo Nordisk (NVO) FAQ

As of the most recent data (June 2026), NVO shows a other current liabilities of $45B. That compares with $150B in the prior-year period — down 69.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVO's other current liabilities is now $45B (was $150B) — a 69.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk is outperforming or lagging.

Tracking NVO's other current liabilities over time shows whether Novo Nordisk is scaling, shrinking, or reshaping that part of the business. The current reading is $45B That compares with $150B in the prior-year period — down 69.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Novo Nordisk's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $45B) with ownership activity and broader fundamentals.

Novo Nordisk's other current liabilities is $45B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.